REBOOTING THE STATISTIC THAT 5% OF ELIGIBLE PATIENTS PARTICIPATE IN CLINICAL TRIALS.

The article offers information about the limitations and flaws in the widely-accepted statistic of eligible patients participate in clinical trials. It argues that this figure needs a serious reboot as it fails to consider various factors and is based on a narrow patient population. It also mentions that the evolving nature of investigational therapies and strategies for engaging study volunteers are not accounted for in this outdated estimate.